High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosusSarah Reid, Andrei Alexsson, Martina Frodlund, David Morris, Johanna K Sandling, Karin Bolin, Elisabet Svenungsson, Andreas Jönsen, Christine Bengtsson, Iva Gunnarsson, Vera Illescas Rodriguez, Anders Bengtsson, Sabine Arve, Solbritt Rantapää-Dahlqvist, Maija-Leena ElorantaSee the full list of authors
11 December 2019
Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosusMaria Grigoriou, Aggelos Banos, Anastasia Filia, Pavlos Pavlidis, Stavroula Giannouli, Vassiliki Karali, Dionysis Nikolopoulos, Antigone Pieta, George Bertsias, Panayotis Verginis, Ioannis Mitroulis, Dimitrios T Boumpas
28 November 2019
NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosusPetrus Linge, Sabine Arve, Lina M Olsson, Dag Leonard, Christopher Sjöwall, Martina Frodlund, Iva Gunnarsson, Elisabet Svenungsson, Helena Tydén, Andreas Jönsen, Robin Kahn, Åsa Johansson, Lars Rönnblom, Rikard Holmdahl, Anders Bengtsson
8 November 2019
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatmentChristina Adamichou, Dionysis Nikolopoulos, Irini Genitsaridi, Alessandra Bortoluzzi, Antonis Fanouriakis, Emmanouil Papastefanakis, Eleni Kalogiannaki, Irini Gergianaki, Prodromos Sidiropoulos, Dimitrios T Boumpas, George K Bertsias
8 November 2019
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trialJing He, Ruijun Zhang, Miao Shao, Xiaozhen Zhao, Miao Miao, Jiali Chen, Jiajia Liu, Xiaoying Zhang, Xia Zhang, Yuebo Jin, Yu Wang, Shilei Zhang, Lei Zhu, Alexander Jacob, Rulin JiaSee the full list of authors
19 September 2019
Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trialChi Chiu Mok, Kwok Hung Chan, Ling Yin Ho, Yim Fong Fung, Wai Fong Fung, Patrick Chiu Yat Woo
17 September 2019
Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapseAlexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, Hervé Devilliers, Hans Yssel, Laura Garrido Castillo, Fleur Cohen-Aubart, Julien Haroche, Miguel Hié, Marc Pineton de Chambrun, Makoto Miyara, Micheline Pha, Flore Rozenberg, Guy Gorochov, Zahir Amoura
30 September 2019
A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: international collaborative study to evaluate a candidate preparationBernard J Fox, Jason Hockley, Peter Rigsby, Carl Dolman, Pier Luigi Meroni, Johan Rönnelid
5 September 2019
Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosusLina Odqvist, Zala Jevnikar, Rebecca Riise, Lisa Öberg, Magdalena Rhedin, Dag Leonard, Linda Yrlid, Sonya Jackson, Johan Mattsson, Sambit Nanda, Philip Cohen, Axel Knebel, Simon Arthur, Kristofer Thörn, Elisabet SvenungssonSee the full list of authors
12 July 2019
Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individualsNeelakshi R Jog, Kendra A Young, Melissa E Munroe, Michael T Harmon, Joel M Guthridge, Jennifer A Kelly, Diane L Kamen, Gary S Gilkeson, Michael H Weisman, David R Karp, Patrick M Gaffney, John B Harley, Daniel J Wallace, Jill M Norris, Judith A James
19 June 2019
